Merck’s 2026 Shift: Pharma’s Future Unclear
Merck's 2025 restructuring reshapes pharma. See why companies like BioGen must adapt their strategy amid industry's focus on high-margin drugs.
Merck's 2025 restructuring reshapes pharma. See why companies like BioGen must adapt their strategy amid industry's focus on high-margin drugs.
Made an IEEPA error? Learn how to recover funds through OFAC refund mechanisms. Avoid penalties; see 2025's 1,500+ cases.
How did emerging markets surprise in 2020? See 5 key strategies, from digital infra to fiscal policy, for future economic resilience.
Is your chemical firm ready for 2026? See why $150B in R&D spending means big changes for sustainability, new materials, and AI in chemicals.
North America faces 15% supply chain delays by 2026. Geopolitical risk demands new sourcing and logistics. See strategies for businesses.
Wilmington's tech boom faces challenges. See how a $75M venture capital surge highlights growing pains for this emerging innovation hub.
Is pneumonic plague a 2026 threat? Learn how this ancient disease, spread person-to-person, could become a geopolitical risk amid global instability.
North Carolina's film and digital asset sectors are converging for a $1.2 billion economic boom. See how new tech, incentives, and jobs are driving growth.
Ohio secured $2.7B in foreign investment for 2024. See how this influx impacts manufacturing, creates 2,000+ jobs, and what's next.
Will global commerce be frictionless by 2026? Learn how digital solutions, like 70+ countries' single windows, are cutting costs and delays.